AlphaYouSB
Insider selling
Sharon Benzeno sold $3.5M of Adaptive Biotechnologies Corp (ADPT) stock
Sharon Benzeno, Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp (ADPT), sold 165,802 shares of ADPT stock worth $3.5M, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 26, 2026, 4 days before it was made public.
ADPT has moved +32.9% since the trade date, from $20.96 to $27.86 (Sep 21, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 4 days
- Price since
- +32.9%
- Role
- Chief Commercial Ofc Imm Med
- Source
- SEC Form 4
More ADPT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.